Literature DB >> 9457446

Alcohol, ischemic heart disease, and the French paradox.

J Constant1.   

Abstract

Studies comparing alcohol intake and ischemic heart disease have shown either an inverse relation or a U-shaped curve in which the equivalent of two drinks per day of any kind of alcohol is associated with a decreased incidence of coronary disease compared with no drinks, while higher doses result in an increased risk of infarction and stroke. The cardioprotective effects of most alcoholic beverages are probably due to an elevation of high-density lipoprotein and the ability of alcohol to prevent platelet aggregation and increase fibrinolysis; however, there is an increased favorable effect from red wine. The unique cardioprotective properties of red wine reside in the action of flavonoids which are minimal in white wine (with the exception of champagne). The best researched flavonoids are resveratrol and quercetin, which confer antioxidant properties more potent than alpha-tocopherol. Grape juice has about half the amount of flavonoids by volume as red wine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9457446     DOI: 10.1097/00019501-199710000-00007

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  16 in total

1.  Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection.

Authors:  Ru Zhou; Masayuki Fukui; Hye Joung Choi; Bao Ting Zhu
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

2.  Protective effect of gallic acid against arsenic-induced anxiety-/depression- like behaviors and memory impairment in male rats.

Authors:  Noreen Samad; Sadia Jabeen; Imran Imran; Iqra Zulfiqar; Kainat Bilal
Journal:  Metab Brain Dis       Date:  2019-05-22       Impact factor: 3.584

3.  The resveratrol derivatives trans-3,5-dimethoxy-4-fluoro-4'-hydroxystilbene and trans-2,4',5-trihydroxystilbene decrease oxidative stress and prolong lifespan in Caenorhabditis elegans.

Authors:  Nadine Fischer; Christian Büchter; Karoline Koch; Sabrina Albert; René Csuk; Wim Wätjen
Journal:  J Pharm Pharmacol       Date:  2016-11-23       Impact factor: 3.765

4.  Suppression of human monocyte tissue factor induction by red wine phenolics and synthetic derivatives of resveratrol.

Authors:  Gurjeet Kaur; Marinella Roberti; Francis Raul; Usha R Pendurthi
Journal:  Thromb Res       Date:  2006-02-28       Impact factor: 3.944

5.  Effect of wine phenolics on cytokine-induced C-reactive protein expression.

Authors:  G Kaur; L V M Rao; A Agrawal; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

6.  Management of oxidative stress in the CNS: the many roles of glutathione.

Authors:  B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

7.  Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro.

Authors:  S Madlener; P Saiko; C Vonach; K Viola; N Huttary; N Stark; R Popescu; M Gridling; N T-P Vo; I Herbacek; A Davidovits; B Giessrigl; S Venkateswarlu; S Geleff; W Jäger; M Grusch; D Kerjaschki; W Mikulits; T Golakoti; M Fritzer-Szekeres; T Szekeres; G Krupitza
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

Review 8.  Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models.

Authors:  Nilendra Singh; Megha Agrawal; Sylvain Doré
Journal:  ACS Chem Neurosci       Date:  2013-06-24       Impact factor: 4.418

9.  Resveratrol attenuates the Na(+)-dependent intracellular Ca(2+) overload by inhibiting H(2)O(2)-induced increase in late sodium current in ventricular myocytes.

Authors:  Chunping Qian; Jihua Ma; Peihua Zhang; Antao Luo; Chao Wang; Zhiqiang Ren; Linghao Kong; Shuo Zhang; Xiaojing Wang; Ying Wu
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

Review 10.  Site-specific antioxidative therapy for prevention of atherosclerosis and cardiovascular disease.

Authors:  Hajime Otani
Journal:  Oxid Med Cell Longev       Date:  2013-04-30       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.